A Gutsy Technical Call on a Biotech ETF

On Wednesday, the technical outlook for the iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB) was highlighted and the prognosis can easily be summed up: IBB was still honoring its multi-year uptrend, but it and the other biotech ETFs are in precarious technical positions. IBB, the largest biotech...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.